Financials

News Discussions Technicals Forecast Seasonals

2142 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

HBM Holdings Ltd. is an investment company, which engages in the discovery and development of differentiated antibody therapeutics in oncology and immunology disease areas. It operates through the following geographical segments: Europe, Mainland China, United States, and Others. The company was founded by Xiao Xiang Chen, Qi He, Schweizer Liang, Mai Jing Liao, Xiao Xi Liu, and Jing Song Wang on July 20, 2016 and is headquartered in Suzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

2142 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company